Astellas taps into Pandion’s platform for bispecifics development
Astellas and Pandion join forces to develop treatments for autoimmune pancreatic diseases using the latter’s modular immune effector.
Archives for November 5, 2019
Modeling, simulation firm supporting radiation countermeasure development
The modeling and simulation solutions provider Simulations Plus has been contracted to support countermeasure development for acute radiation syndrome in a partnership with a global pharma company.
Eversana taps Cornerstone’s research services, expands insights offering
Eversana acquires Cornerstone Research Group with an aim to expand its portfolio of Health Economics and Outcomes Research (HEOR).